MarketCap
Facebook
X
Telegram
Forward Pharma A/S Current Ratio | FWP
Current Ratio Jährlich Forward Pharma A/S
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 74.5 | 131 | 74.5 | 5.2 | 22.2 | 29.4 | 32 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 131 | 5.2 | 52.7 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Pliant Therapeutics
PLRX
|
5.12 | $ 0.78 | -2.19 % | $ 47.9 M |  USA |
 |
Pharming Group N.V.
PHAR
|
1.78 | $ 13.02 | -1.06 % | $ 8.97 B |  Niderland |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
7.25 | - | -6.97 % | $ 657 M | USA |
 |
Capricor Therapeutics
CAPR
|
7.1 | $ 8.91 | -9.54 % | $ 414 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.94 | $ 29.06 | -1.09 % | $ 1.36 B | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
11.8 | - | 1.68 % | $ 4.65 B |  China |
 |
Aquestive Therapeutics
AQST
|
0.827 | $ 3.52 | -0.56 % | $ 376 M | USA |
 |
Jaguar Health
JAGX
|
0.672 | $ 0.44 | -0.21 % | $ 1.03 M | USA |
 |
Arvinas
ARVN
|
2.53 | $ 6.9 | 2.07 % | $ 489 M | USA |
 |
Cerus Corporation
CERS
|
1.41 | $ 1.95 | -6.04 % | $ 372 M | USA |
 |
Beam Therapeutics
BEAM
|
6.1 | $ 25.16 | -6.88 % | $ 2.49 B | USA |
 |
Pulmatrix
PULM
|
4.97 | $ 1.39 | 2.58 % | $ 5.08 B | USA |
 |
Fortress Biotech
FBIO
|
1.5 | $ 1.9 | -4.52 % | $ 53 M | USA |
 |
Inhibrx
INBX
|
1.16 | $ 90.63 | -1.21 % | $ 4.27 B | USA |
 |
Entera Bio Ltd.
ENTX
|
5.53 | $ 3.24 | -0.31 % | $ 150 M |  Israel |
 |
Flexion Therapeutics, Inc.
FLXN
|
4.09 | - | - | $ 459 M | USA |
 |
Legend Biotech Corporation
LEGN
|
2.37 | $ 20.25 | -16.63 % | $ 7.46 B | USA |
 |
CytomX Therapeutics
CTMX
|
2.88 | $ 2.0 | 0.76 % | $ 276 M | USA |
 |
Krystal Biotech
KRYS
|
11.7 | $ 306.47 | 1.13 % | $ 8.87 B | USA |
 |
Kura Oncology
KURA
|
1.31 | $ 7.56 | -0.13 % | $ 663 M | USA |
 |
Inhibikase Therapeutics
IKT
|
21.8 | $ 1.58 | -6.25 % | $ 155 M | USA |
 |
Heron Therapeutics
HRTX
|
1.06 | $ 0.38 | 1.38 % | $ 63.3 M | USA |
 |
Inovio Pharmaceuticals
INO
|
1.48 | $ 1.47 | -2.98 % | $ 68.9 M | USA |
 |
Corvus Pharmaceuticals
CRVS
|
7.17 | $ 11.36 | 0.09 % | $ 897 M | USA |
 |
Aytu BioScience
AYTU
|
1.41 | $ 1.83 | 2.23 % | $ 22.5 M | USA |
 |
Heat Biologics, Inc.
HTBX
|
31.1 | - | -5.76 % | $ 99.8 M | USA |
 |
Innoviva
INVA
|
80.3 | $ 19.08 | 0.39 % | $ 1.29 B | USA |
 |
BioCardia
BCDA
|
1.36 | $ 0.95 | 2.66 % | $ 6.33 M | USA |
 |
Kindred Biosciences, Inc.
KIN
|
9.08 | - | 0.11 % | $ 419 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
12.7 | $ 2.3 | -5.35 % | $ 14.7 B |  Australia |
 |
Shineco, Inc.
TYHT
|
5.25 | - | -3.90 % | $ 97.2 M | China |
 |
Millendo Therapeutics, Inc.
MLND
|
5.12 | - | -5.36 % | $ 20.2 M | USA |
 |
Certara
CERT
|
3.15 | $ 12.21 | -0.08 % | $ 1.96 B | USA |
 |
Dyadic International
DYAI
|
1.14 | $ 0.39 | 1.16 % | $ 14.1 M | USA |
 |
Intec Pharma Ltd
NTEC
|
2.81 | - | -12.45 % | $ 17.7 M | Israel |
 |
Anika Therapeutics
ANIK
|
14.4 | $ 13.42 | -7.89 % | $ 192 M | USA |
 |
Aprea Therapeutics
APRE
|
9.42 | $ 0.45 | -9.44 % | $ 2.94 M | USA |
 |
Galectin Therapeutics
GALT
|
0.134 | $ 3.4 | -1.73 % | $ 217 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
4.43 | $ 73.22 | -2.41 % | $ 7.6 B | USA |
 |
Progenity, Inc.
PROG
|
1.74 | - | -3.47 % | $ 164 M | USA |
 |
Genprex
GNPX
|
4.62 | $ 2.1 | 1.94 % | $ 1.96 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
4.37 | - | 1.52 % | $ 136 M | USA |
 |
Innate Pharma S.A.
IPHA
|
2.03 | $ 1.54 | 1.98 % | $ 138 M |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
4.02 | - | -1.19 % | $ 28.7 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
5.04 | $ 57.1 | -0.14 % | $ 11 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
3.03 | $ 1.19 | -4.03 % | $ 6.51 M | USA |
 |
Enanta Pharmaceuticals
ENTA
|
1.3 | $ 11.24 | -2.01 % | $ 240 K | USA |
 |
SIGA Technologies
SIGA
|
10.6 | $ 3.14 | -3.83 % | $ 225 M | USA |
 |
Milestone Pharmaceuticals
MIST
|
1.58 | $ 0.68 | -7.49 % | $ 72.2 M |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
3.9 | $ 94.9 | -3.91 % | $ 7.04 B | USA |